Y-Mabs Therapeutics Inc - YMAB - stock price prediction, stock price target, analyst ratings from 9 analysts

Y-Mabs Therapeutics Inc has a share price target of US$ 9, revenue growth forecast of -5.1%, and profit growth estimate of 3.2% for FY25, based on top 9 analyst calls.